STIM1 and hepatocellular carcinoma: To further investigate the promoting effect of STIM1 on acquired SR in HCC cell lines, we conducted proliferation and sorafenib-induced cell death experiments using Con-, SR-, and SR STIM1 KD-Hep3B and MHCC97H cells.